SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Charlie Smith who wrote (1698)3/1/2000 3:39:00 PM
From: nihil   of 1754
 
An implicitly cooperating duopoly may be profitable to both companies but both must be willing to share. An attempt by either party to gain a monopoly by price cutting not only destroys profitability for both, but is illegal under the Sherman Act Sec. 2. The common price of the duopolists must be low enough to exclude undifferentiated third parties. BOL has long experience in similar markets. I think they are willing to share, but their target share may be bigger than VISX would like to yield. Because of wealth differences, I think VISX must move over and make room.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News